DVONCH JEROME J
SEC insider (Form 3/4/5 filer). CIK 0001518735. Chief Financial Officer at Sonoma Pharmaceuticals, Inc. (SNOA). 4 reported Form 4/5 transactions since Sep 2024; latest on Jul 9, 2026. Located in BOULDER, CO.
Companies DVONCH JEROME J has filed insider reports for
- Sonoma Pharmaceuticals, Inc. (SNOA): Officer, Chief Financial Officer
DVONCH JEROME J
CIK: 0001518735
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Sonoma Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 9, 2026SNOA
Sonoma Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
10K shares- - Jan 2, 2026SNOA
Sonoma Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
5K shares- - Jun 19, 2025SNOA
Sonoma Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
13.5K shares- - Jan 2, 2025SNOA
Sonoma Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
10K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 9, 2026 | SNOA Sonoma Pharmaceuticals, Inc. | Award Restricted Stock Units | 10,000 | - | - | Direct |
| Jan 2, 2026 | SNOA Sonoma Pharmaceuticals, Inc. | Award Restricted Stock Units | 5,000 | - | - | Direct |
| Jun 19, 2025 | SNOA Sonoma Pharmaceuticals, Inc. | Award Restricted Stock Units | 13,500 | - | - | Direct |
| Jan 2, 2025 | SNOA Sonoma Pharmaceuticals, Inc. | Award Restricted Stock Units | 10,000 | - | - | Direct |
1-4 of 4 transactions